Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Outlook Therapeutics
(41O.F) Q2 2025
Earnings
41O.F
May 15
Confirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.94
-0.74
-0.55
-0.36
Details
Expected EPS
-0.4850530956
Actual EPS
-0.357432
Surprise EPS
0.13
Surprise Percent
+26.31%
Description
Outlook Therapeutics (41O.F) has reported earnings of -0.357432 per share for Q2 2025.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login